Praxis Precision Medicines Inc (PRAX)

Oct 12, 2025

Price momentum metrics for Praxis Precision Medicines Inc. explainedQuarterly Profit Summary & Short-Term Trading Alerts - newser.com

Oct 12, 2025

Oct 10, 2025

Multi asset correlation models including Praxis Precision Medicines Inc.Weekly Earnings Recap & Safe Entry Momentum Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

How institutional ownership impacts Praxis Precision Medicines Inc. stockExit Point & Verified High Yield Trade Plans - newser.com

Oct 10, 2025

Oct 08, 2025

Did the ReCode Partnership Just Shift Praxis Precision Medicines' (PRAX) Innovation Narrative in Neuroscience? - Yahoo Finance

Oct 08, 2025

Oct 08, 2025

Assessing Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum - Yahoo

Oct 08, 2025

Oct 06, 2025

Why Praxis Precision Medicines Inc. is moving todayJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com

Oct 06, 2025

Oct 06, 2025

Published on: 2025-10-06 01:53:19 - newser.com

Oct 06, 2025

Oct 06, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 06, 2025

Oct 05, 2025

Is Praxis Precision Medicines Inc a good long term investmentOptions Trading Strategies & Minimal Capital Growth Plans - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Visual analytics tools that track Praxis Precision Medicines Inc. performance2025 Market Trends & Growth Focused Stock Pick Reports - newser.com

Oct 05, 2025

Oct 05, 2025

Real time pattern detection on Praxis Precision Medicines Inc. stockTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com

Oct 05, 2025

Oct 05, 2025

Praxis Precision Medicines Inc. stock trend forecastQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com

Oct 05, 2025

Oct 04, 2025

Praxis Precision Medicines (PRAX): Evaluating Valuation Potential Following Brain-Targeted Delivery Collaboration - Sahm

Oct 04, 2025

Oct 03, 2025

Is Praxis Precision Medicines Inc. stock undervalued vs historical averagesJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com

Oct 03, 2025

Oct 03, 2025

Real time scanner hits for Praxis Precision Medicines Inc. explainedQuarterly Growth Report & Real-Time Market Sentiment Reports - newser.com

Oct 03, 2025

Oct 03, 2025

What technical models suggest about Praxis Precision Medicines Inc.’s comebackGap Up & Consistent Profit Focused Trading Strategies - newser.com

Oct 03, 2025

Oct 03, 2025

Could PRAX's Focus on Delivery Innovation Signal a Shift in CNS Therapy Ambitions? - Sahm

Oct 03, 2025

Oct 03, 2025

Chart based analysis of Praxis Precision Medicines Inc. trendsJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Will earnings trigger a reversal in Praxis Precision Medicines Inc.July 2025 Institutional & High Accuracy Buy Signal Tips - newser.com

Oct 03, 2025

Oct 02, 2025

Published on: 2025-10-02 21:58:13 - newser.com

Oct 02, 2025

Oct 02, 2025

Risk vs reward if holding onto Praxis Precision Medicines Inc.July 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 02, 2025

Oct 02, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 02, 2025

Oct 02, 2025

Praxis Precision Medicines announces inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 02, 2025

Oct 02, 2025

4,200 RSUs: Praxis Precision Medicines Grants Awards to 3 New Hires, Vesting Over 4 Years - Stock Titan

Oct 02, 2025

Oct 02, 2025

Piper Sandler reiterates Overweight rating on Praxis Precision Medicines stock - Investing.com

Oct 02, 2025

Oct 01, 2025

Published on: 2025-10-01 08:22:08 - newser.com

Oct 01, 2025

Sep 30, 2025

Published on: 2025-09-30 15:59:01 - newser.com

Sep 30, 2025

Sep 30, 2025

Should You Stay Invested in Aspinwall and Company Limited for the Long HaulStock Buyback Announcements & Affordable Trading Plans - earlytimes.in

Sep 30, 2025

Sep 29, 2025

ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update - Business Wire

Sep 29, 2025